Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-02-03 @ 3:07 AM
Study NCT ID:
NCT03387592
Status:
TERMINATED
Last Update Posted:
2025-03-10
First Post:
2017-12-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas
Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRST100.22
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None